Qin hui Fu

Qin hui Fu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2017 in Trials
Verified
Journal Article
Open access
PDF file
JWJun Wang
Jun Wang
JPJian Pei
Jian Pei
DKDhiaedin Khiati
Dhiaedin Khiati
QFQin hui Fu
Qin hui Fu
XCXiao Cui
Xiao Cui
YMYuhong Ma
Yuhong Ma
Scalp acupuncture has shown a remarkable treatment efficacy on motor dysfunction in patients with stroke in China, especially the motor area of Jiao’s scalp acupuncture, which is the most widely used treatment. However, previous studies have summarized that the clinical curative effect of acupuncture treatment for stroke remains uncertain. Meanwhile, no randomized controlled trials on Jiao’s scalp acupuncture have been performed. The aim of this study is to evaluate the efficacy and safety of Jiao’s scalp acupuncture for motor dysfunction in ischemic stroke. This is an assessor- and analyst-blinded, randomized controlled trial. One hundred and eight stroke patients with motor dysfunction meeting the inclusion criteria will be allocated by a 1:1 ratio into either an acupuncture treatment group or a control group. Stroke patients in the control group will receive conventional rehabilitation treatment, whereas a combination of Jiao’s scalp acupuncture and conventional rehabilitation treatment will be applied to the acupuncture group. Forty treatment sessions will be performed over an 8-week period. The Fugl-Meyer Assessment scale will be assessed as the primary outcome measure. The Modified Barthel Index, the Stroke-Specific Quality of Life, and the Stroke Syndrome of Traditional Chinese Medicine scales will be selected as secondary outcome measurements. All assessments will be conducted at baseline, week 4 (treatment 20), week 8 (treatment 40), week 12 (follow-up), and week 16 (follow-up). This is the first trial evaluating the efficacy and safety of Jiao’s scalp acupuncture for motor dysfunction in ischemic stroke. The results of this trial are expected to provide relevant evidence demonstrating that Jiao’s scalp acupuncture can be used as an effective rehabilitation treatment method for improving motor dysfunction in ischemic stroke. ClinicalTrials.gov, NCT02871453 . Registered on 17 July 2016.

1 January 2020 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
JXJia Xu
Jia Xu
JPJian Pei
Jian Pei
QFQin hui Fu
Qin hui Fu
YZYi-Jun Zhan
Yi-Jun Zhan
Background. Stroke scales of traditional Chinese medicine (SSTCM) are promoted for use in the early prognosis. The current lines of evidence to support their performance evaluation are uneven. This pilot study aimed to investigate the correlation between traditional Chinese medicine (TCM) symptoms in the early stages of acute ischemic stroke and the prognosis of motor dysfunction through one‐year of follow‐up. Methods. Three hundred and fifteen patients were retrospected at Longhua Hospital from January 2016 to December 2017. All patients had received standard treatments combined with acupuncture therapy, including both electroacupuncture and scalp acupuncture for a median course of five months. The observed outcomes were the Fugl‐Meyer assessment (FMA), the modified Barthel index (MBI), and the modified Rankin scale (mRS) at one‐year follow‐up after stroke onset by multiple linear regression analysis combined with ROC curves. Results. The favorable outcome rate was 74.3%, with the recurrence rate of 20.3% in the follow‐up. In multiple linear regression, 10 TCM symptoms (MBI regression model) were related to the prognosis of MBI (DW 1.409, Ad. R2 0.654) and 10 TCM symptoms (FMA regression model) were related to the FMA outcome (DW 1.446, Ad R2 0.620). The two models were selected to have nine repeated symptoms (repeated model). In the ROC curves, the three models were compared with the NIHSS score, and the MBI regression model reflected the highest efficiency. Conclusions. The combination of 10 TCM symptoms, once onset occurred, including hemiplegia, restlessness, hemianesthesia, short breath, headache, constipation, night sweat, tinnitus, thirsty, and gurgling with sputum, may affect the recovery of motor dysfunction. Furthermore, the improvements of TCM symptoms dynamically after treatment would be observed in a large prospective cohort. This trial is registered with NCT01806233.

28 June 2022 in Chinese Medicine and Culture
Verified
Journal Article
Open access
SDSi-Si Du
Si-Si Du
QFQin hui Fu
Qin hui Fu
JPJian Pei
Jian Pei
HZHua Zhou
Hua Zhou
EWEr-Liang Editor(S): Wang
Er-Liang Editor(S): Wang
Objective: We evaluated the efficacy and safety of transdermal preparations of Sinomenium acutum (SA) for rheumatoid arthritis (RA). Methods: Randomized controlled trials (RCTs) of SA transdermal preparations for RA were extracted from relevant databases and screened in accordance with the inclusion criteria. The Cochrane System Evaluation Manual (version 5.1.0) was used to assess the quality of the included trials. We used the Cochrane Review Manager (version 5.4) to conduct the meta-analysis. Results: Six trials comprising 436 patients (220 patients in the treatment group and 216 patients in the control group) were analyzed. The meta-analysis indicated that SA transdermal preparations in combination with disease-modifying antirheumatic drugs (DMARDs) enhanced the overall effect (odds ratio [OR] 3.97, 95% confidence interval [CI] [2.25, 7.00], P<0.00001), decreased visual analogue scale (VAS) results (mean difference [MD] –0.64, 95% CI [–1.20, –0.09], P=0.02), decreased laboratory indexes including the erythrocyte sedimentation rate (ESR) (MD –4.36, 95% CI [–5.63, –3.08], P<0.00001) and C-reactive protein (CRP) (MD –3.6, 95% CI [–3.99, –3.21, P<0.00001]), and decreased the Disease Activity Score-28 (DAS28) (MD –0.41, 95% CI [–0.78, –0.03], P=0.03). The results suggest that combination therapy did not shorten the duration of morning stiffness (DMS; standardized MD [SMD] –6.13, 95% CI [–17.33, 5.06], P=0.28) or reduce rheumatoid factor (RF) laboratory indexes (SMD –0.85; 95% CI [–2.19, 0.49], P=0.21). Only one study reported adverse reactions, and thus, it was difficult to determine whether adverse drug reactions in the combination therapy group were significantly different from those in the control group. Conclusion: We found that SA transdermal preparations combined with DMARDs may have greater clinical efficacy than DMARDs for RA. More well-designed and high-quality RCTs are required to verify the findings and determine whether transdermal preparations cause fewer adverse events.

3 March 2026 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
PLPeiqi Li
Peiqi Li
QYQianwen Yang
Qianwen Yang
JPJian Pei
Jian Pei
CVCharles Savona Ventura
Charles Savona Ventura
LZLinda Zhong
Linda Zhong
QFQin hui Fu
Qin hui Fu
Insomnia features include persistent difficulties in sleep initiation and sleep maintenance, leading to significant daytime dysfunction and diminished quality of life. While acupuncture is increasingly utilized in the management of insomnia, its specific efficacy in alleviating daytime dysfunction remains inadequately substantiated. This systematic review aims to address this evidence gap. A total of 5,037 articles from 6 electronic databases were searched and screened. Data analysis was performed using Review Manager 5.4 software and Stata 13. The Cochrane tool for assessing the risk of bias in randomized trials (RoB2) and GRADE were used to evaluate the quality of the RCTs and the evidence. Eighteen randomized controlled trials (RCTs) encompassing a total of 1,767 patients were analyzed. Data of the Montreal Cognitive Assessment (MoCA), Auditory Verbal Memory Test (AVMT), and Fatigue Scale-14 (FS-14) scores were extracted and aggregated, along with the scores of the Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI). Moderate-quality evidence showed that acupuncture therapies could not only significantly reduce insomnia severity but also enhance memory ability and relieve cognitive impairment. Low-quality evidence presented that acupuncture could improve sleep quality and reduce fatigue in patients with chronic primary insomnia. Although heterogeneity was observed across several synthesized outcomes, the results were robust. Systematic review registration: The research protocol was registered in PROSPERO (ID: CRD42023442722).

23 June 2021
Verified
Report
Open access
SDSisi DU
Sisi DU
QFQin hui Fu
Qin hui Fu
JPJian Pei
Jian Pei
HZHua Zhou
Hua Zhou
INPLASY202160085 Systematic review and Meta-analysis of transdermal preparations of Sinomenium acutum in rheumatoid arthritis Keywords: Sinomenium acutum;Sinomenine;transdermal drug delivery system(TDDS);rheumatoid arthritis;systematic review. Download PDF – 202160085 Review Status: Ongoing

14 February 2025
Verified
Report
Closed access
KJKaixin Jin
Kaixin Jin
QFQin hui Fu
Qin hui Fu
INPLASY202520075 Acupuncture for Chemotherapy-induced Peripheral Neuropathy in Patients with Gastrointestinal Cancer: Protocol for a Systematic Review and Meta-analysis Keywords: Acupuncture, Gastr…